Biopharma company raises $21.5M to treat inflammatory skin disorders
A biopharma management company has created a new business that will use liver X receptor agonists to take on dermatological disorders. NeXeption has raised $21.5 million in a Series A financing round to form Alexar Therapeutics, according to a company statement. New Science Ventures and Third Point Ventures led the financing round and will each […]